Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:10.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; deletions remove a government-funding notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:14:14.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a revision note (v3.4.1); removed the previous revision note (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:30:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates in the history page include a Show glossary option and color-coded change highlights (green for additions, red for deletions) with a Revision: v3.4.0 banner. Additionally, the No FEAR Act data entry and the older Revision: v3.3.4 entry were removed.
    Difference
    0.6%
    Check dated 2026-01-28T06:15:00.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the page history, replacing the previous v3.3.3. No core content or study-related details were changed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:55.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:12:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.